Persistency and clinical outcomes associated with latanoprost and beta-blocker monotherapy: evidence from a European retrospective cohort study.
- 1 July 2003
- journal article
- research article
- Published by SAGE Publications in European Journal of Ophthalmology
- Vol. 13 (4_suppl), 21-29
- https://doi.org/10.1177/112067210301304s03
Abstract
To evaluate persistency (time on initial therapy) and the clinical impact of latanoprost versus beta-blocker monotherapy in treating glaucoma.Keywords
This publication has 28 references indexed in Scilit:
- Resource Use and Costs of Patients With Glaucoma or Ocular Hypertension: A One-year Study Based on Retrospective Chart Review in the NetherlandsJournal of Glaucoma, 2001
- The advanced glaucoma intervention study (AGIS): 7. the relationship between control of intraocular pressure and visual field deteriorationAmerican Journal of Ophthalmology, 2000
- The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAmerican Journal of Ophthalmology, 1998
- Costs of Treating Primary Open-Angle Glaucoma and Ocular HypertensionJournal of Glaucoma, 1998
- Number of people with glaucoma worldwide.British Journal of Ophthalmology, 1996
- Prevalence of open‐angle glaucoma in central SwedenActa Ophthalmologica Scandinavica, 1996
- The Economic Burden of Glaucoma in the UKPharmacoEconomics, 1995
- Intraocular Pressure-Dependent Progression of Visual Field Loss in Advanced Primary Open-Angle Glaucoma: A 15-Year Follow-UpOphthalmologica, 1993
- CNS-related (side-)effects of ?-Blockers with special reference to mechanisms of actionEuropean Journal of Clinical Pharmacology, 1985
- Treatment of GlaucomaAnnual Review of Medicine, 1984